TE
MDGL icon

Tema ETFs’s Madrigal Pharmaceuticals MDGL Stock Holding History

Tema ETFs’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$805K Sell
1,499
-52
-3% -$26.6K 0.03% 332
2026
Q1 		$812K Sell
1,551
-20
-1% -$9.55K 0.05% 276
2025
Q4 		$915K Sell
1,571
-50
-3% -$25.5K 0.07% 254
2025
Q3 		$743K Sell
1,621
-180
-10% -$67.2K 0.06% 306
2025
Q2 		$545K Sell
1,801
-477
-21% -$142K 0.14% 133
2025
Q1 		$755K Sell
2,278
-1,342
-37% -$441K 0.23% 100
2024
Q4 		$1.12M Buy
+3,620
New +$1.02M 0.46% 59

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tema ETFs's MDGL Position: Q2 2026 in Review

Tema ETFs reduced its Madrigal Pharmaceuticals (MDGL) stake by 3.4% in Q2 2026, selling an estimated $26.6K and leaving 1,499 shares worth $805K. The position accounts for 0.03% of the portfolio, ranked #332.

Tema ETFs first reported a position in MDGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.12M in Q4 2024. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Tema ETFs held 1,499 shares of Madrigal Pharmaceuticals worth $805K as of Q2 2026.
  • Tema ETFs sold 52 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $26.6K.
  • Madrigal Pharmaceuticals made up 0.03% of Tema ETFs's portfolio in Q2 2026, its #332 holding.
  • Tema ETFs first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's Madrigal Pharmaceuticals position peaked at $1.12M in Q4 2024.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.